Table 3 Overview and comparison of microbiological detections in two cohorts of patients with respiratory tract infections

Viruses

62

24

–

–

 Influenza A virus

29 (30)

0

− 30% (− 41% to − 20%)

< 0.0001

 Human metapneumovirus

16 (17)

0

− 17% (− 26% to − 8%)

< 0.0001

 Rhino-/enterovirus

3 (3)

12 (15)

12% (1% to 21%)

0.0061

 Coronavirus (SARS-CoV-2)

0

10 (13)

13% (3% to 20%)

0.0003

 Respiratory syncytial virus

7 (7)

0

− 7% (− 15% to 0%)

0.0164

 Coronavirus (229E, OC43, HKU1, NL63)

5 (5)

0

− 5% (− 12% to 1%)

0.0641

 Parainfluenza virus

2 (2)

1 (1)

− 1% (− 7% to 6%)

> 0.9999

 Adenovirus

0

1 (1)

1% (− 5% to 6%)

0.4545

Bacteria

108

79

–

–

 H. influenzae

35 (36)

21 (26)

− 10% (− 24% to 4%)

0.1934

 S. pneumoniae

24 (25)

12 (15)

− 10% (− 22% to 3%)

0.1331

 S. aureus

7 (7)

18 (23)

15% (4% to 26%)

0.0048

 M. catarrhalis

11 (11)

8 (10)

− 1% (− 11% to 9%)

0.8114

 E. coli

8 (8)

3 (4)

− 5% (− 13% to 4%)

0.3490

 S. agalactiae

6 (6)

5 (6)

0% (− 9% to 8%)

> 0.9999

 P. aeruginosa

3 (3)

2 (3)

1% (− 7% to 7%)

> 0.9999

 K. pneumoniae

3 (3)

1 (1)

− 2% (− 8% to 5%)

0.6270

 S. marcescens

3 (3)

1 (1)

− 2% (− 8% to 5%)

0.6270

 E. cloacae complex

1 (1)

2 (3)

2% (− 6% to 7%)

0.5916

 Proteus spp.

2 (2)

1 (1)

− 1% (− 7% to 6%)

> 0.9999

 K. oxytoca

1 (1)

1 (1)

0% (− 6% to 6%)

> 0.9999

 M. pneumoniae

2 (2)

0

− 2% (− 8% to 4%)

0.5013

 K. variicola

0

2 (3)

3% (− 5% to 8%)

0.2052

 A. calcoaceticus–A. baumanii complex

1 (1)

0

− 1% (− 6% to 5%)

> 0.9999

 L. pneumophila

1 (1)

0

− 1% (− 6% to 5%)

> 0.9999

 S. maltophilia

0

1 (1)

1% (− 5% to 6%)

0.4545

 S. pyogenes

0

1 (1)

1% (− 5% to 6%)

0.4545

Other detections:

4

9

–

–

 C. albicans

3 (3)

8 (10)

7% (− 3% to 15%)

0.1144

 P. jirovecii

1 (1)

1 (1)

0% (− 6% to 6%)

> 0.9999